Skip to main content
Simcere Pharmaceutical Group Limited logo

Simcere Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · S2P ISIN · HK0000658531 HKEX Manufacturing
Open in API
Filings indexed 577 across all filing types
Latest filing 2021-05-25 AGM Information
Country CN China
Listing HKEX S2P

About Simcere Pharmaceutical Group Limited

https://www.simcere.com/en/

Simcere Pharmaceutical Group Limited is an R&D-driven pharmaceutical company specializing in the discovery, development, and commercialization of innovative and branded generic prescription drugs. The company strategically focuses on core therapeutic areas, including neuroscience, anti-oncology, and inflammatory diseases. Simcere emphasizes synergistic innovation, evidenced by its development and launch of multiple Category I innovative pharmaceuticals and its strategic collaborations with global partners to advance novel treatments. These partnerships aim to address significant unmet medical needs and expand the company's portfolio across specialized disease areas.

Recent filings

Filing Released Lang Actions
PROXY FORM FOR ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a proxy form for the Annual General Meeting (AGM) of Simcere Pharmaceutical Group Limited. It includes instructions for appointing a proxy to vote on resolutions at the AGM, such as adopting audited financial statements, declaring dividends, re-electing directors, appointing auditors, and granting mandates to directors. The content is focused on voting procedures and resolutions to be considered at the AGM, not the actual financial report or detailed meeting minutes. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms and voting instructions. The document length is 7214 characters, which is consistent with a detailed proxy form rather than a brief announcement or a full annual report. Therefore, the correct classification is AGM Information (AGM-R).
2021-05-25 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a notice of the Annual General Meeting (AGM) for Simcere Pharmaceutical Group Limited. It includes details about the meeting date, location, agenda items such as adoption of audited financial statements, dividend declaration, re-election of directors, appointment of auditors, and approval of share issuance and repurchase mandates. The document is clearly a formal notice inviting shareholders to the AGM and outlining the business to be conducted. It does not contain the actual annual report, financial statements, or detailed financial data, but rather the meeting notice and resolutions to be voted on. Therefore, it fits the category of AGM Information (AGM-R). The document length is substantial (over 14,000 characters), consistent with a detailed AGM notice rather than a brief announcement. Hence, the classification is AGM-R with high confidence.
2021-05-25 English
(I) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES&#x3b; (II) PROPOSED RE-ELECTION OF RETIRING DIRECTORS&#x3b; (III) PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND AND (IV
AGM Information Classification · 95% confidence The document is a circular from Simcere Pharmaceutical Group Limited dated May 26, 2021, addressing shareholders about the upcoming Annual General Meeting (AGM) scheduled for June 25, 2021. It includes detailed information on proposed resolutions such as granting general mandates to issue and repurchase shares, re-election of retiring directors, declaration and payment of final dividend, and the notice of the AGM itself. The document contains a proxy form, explanatory statements, and a notice of the AGM. The content is typical of materials sent to shareholders in advance of an AGM to inform them and solicit their votes. It is not a report of financial results, audit, or earnings, nor is it a transcript or legal proceeding. It is not merely an announcement of a report but a comprehensive circular with detailed information related to the AGM. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content support this classification with high confidence.
2021-05-25 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2020
Environmental & Social Information Classification · 100% confidence The document is titled 'ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2020' and contains detailed sections on environmental protection, social welfare, governance, and sustainability practices. It covers the period January 1 to December 31, 2020, and is prepared according to ESG guidelines under the Hong Kong Stock Exchange rules. The content includes Chairman's statement, R&D, employee care, environmental protection, compliance, and social responsibility initiatives. There is no indication that this is a financial report, earnings release, or regulatory filing. The focus on ESG factors clearly aligns with the Environmental & Social Information category.
2021-05-25 English
ADOPTION OF THE 2021 RSU SCHEME
Share Issue/Capital Change Classification · 95% confidence The document is an announcement by Simcere Pharmaceutical Group Limited regarding the adoption of a 2021 Restricted Stock Unit (RSU) Scheme. It details the terms, purpose, administration, and conditions of the RSU scheme, including eligibility, vesting, rights attached to RSUs and shares, and circumstances of lapse or cancellation. The content is focused on the company's equity incentive plan and does not contain financial statements, earnings data, or regulatory certifications. It is a formal announcement of a corporate governance and capital structure related plan, specifically about share issuance under an employee incentive scheme. This fits best under the category of Share Issue/Capital Change (SHA), as it relates to the allotment and issuance of shares under a new RSU scheme. The document is lengthy and detailed, indicating it is the announcement itself, not a brief notice or a report publication announcement. Therefore, the classification is SHA with high confidence.
2021-05-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/04/2021, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. It includes confirmations related to compliance with listing rules and legal requirements. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements and confirmations to the exchange, not a financial report or announcement of voting results. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-05-06 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.